Android app Apple app link

Metsera (MTSR) Jumps 20% as Big Pharma Battle Heats Up Over Takeover

By Yahoo! Finance   |   1 month ago
Metsera (MTSR) Jumps 20% as Big Pharma Battle Heats Up Over Takeover

Metsera Inc. (NASDAQ:MTSR) saw a 20% rise in share prices amid a bidding war between Novo Nordisk and Pfizer. Pfizer plans to sue both companies for breaching agreements. Pfizer's discontinued weight loss treatment trial led to the decision to acquire Metsera.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.